CEO of Truffle Capital, co-founder and reference shareholder of DEINOVE

Education: Doctor of Medicine (University Paris VI), immunologist (staff of the Pasteur Institute), Postdoctoral fellow at Stanford University, where in 1987 he published with his colleagues Larry Burg and John Boothroyd a technique for gene amplification now routinely used in laboratories all around the world.

Career: In 1989 founded SangStat, a company specializing in organ transplantation, acquired in 2002 by the American Genzyme for $600 million. Co-founder and CEO of Truffle Capital, a leading European venture capital company which now manages more than €520 million of investment in the sectors of information technology, life sciences and energy.

Patents: Philippe POULETTY is the author of 29 patents and member of the board of directors of 12 European biotechnology and medical device companies. He also founded three biotechnology companies in Europe and the United States.

Mandates & Representations: Honorary President and founder of France Biotech (French association of biotechnology). Former Vice-President of the European Association for the biotechnology industry EuropaBio.

Awards & Distinctions: 1999 laureate of the American Liver Foundation. Chevalier of the Legion of Honor.